Helicobacter Pylori: Gastric Carcinoma and Other Gastrointestinal Neoplasms
DOI:
https://doi.org/10.22376/ijtos.2024.2.4.7-12Keywords:
Biomarkers,, Colorectal carcinoma, Esophageal carcinoma, Gastric MALT lymphoma,, Pancreatic carcinoma, Cancer prophylaxisAbstract
Gastric cancer (GC) remains a critical global health issue, with rising morbidity and mortality rates. Recent epidemiological studies have deepened our understanding of the correlations between GC and other gastrointestinal illnesses, enhancing diagnosis and treatment options. This review highlights key developments in the use of "serological biopsy" for cancer risk assessment, focusing on biomarkers such as pepsinogen, gastrin, and Helicobacter pylori (H. pylori) antibodies. These markers have demonstrated effectiveness in identifying early gastric diseases and predicting infection risks, particularly in high-risk regions. Serologic biopsy is poised for widespread adoption as a non-invasive and cost-effective diagnostic method, offering improved patient monitoring and individualized treatment strategies. Perioperative chemotherapy has emerged as a standard treatment for GC, showing significant improvements in survival, reduced tumor recurrence, and better surgical outcomes. This combination therapy has shifted treatment paradigms by optimizing preoperative tumor reduction, thereby enhancing surgical efficacy. The development of personalized medicine based on serologic biomarkers promises further advances in tailoring treatment to individual cancer characteristics. The review also explores the contentious association between H. pylori and various gastrointestinal cancers, including gastric mucosa-associated lymphoid tissue (MALT) lymphoma, esophageal carcinoma, and colorectal carcinoma. H. pylori has been implicated in the development of MALT lymphoma, with studies showing that eradicating the bacterium can lead to lymphoma remission. The bacteria’s potential role in gastric and esophageal cancers remains debated, as conflicting studies have presented varying degrees of correlation. Similarly, the relationship between H. pylori and colorectal cancer, as well as its association with other gastrointestinal malignancies, requires further exploration. This review covers key epidemiological insights into GC, preventive strategies for colorectal cancer, and emerging diagnostic and treatment indicators for both gastric cancer and lymphoma. It also discusses the evolving understanding of H. pylori's role in gastrointestinal carcinogenesis and its potential impact on future cancer prevention strategies.
References
Camilleri M, Vazquez‐Roque MI, Carlson P, Burton D, Wong BS, Zinsmeister AR. Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders. Neurogastroenterology & Motility. 2011 Nov;23(11):995-e458.
Di Mario F, Moussa AM, Caruana P, Merli R, Cavallaro LG, Cavestro GM, Bò ND, Iori V, Pilotto A, Leandro G, Franzè A. ‘Serological biopsy’in first‐degree relatives of patients with gastric cancer affected by Helicobacter pylori infection. Scandinavian journal of gastroenterology. 2003 Jan 1;38(12):1223-7.
Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Bostick RM, Wu X, Yuan Y. A serological biopsy using five stomach-specific circulating biomarkers for gastric cancer risk assessment: a multi-phase study. Official journal of the American College of Gastroenterology| ACG. 2017 May 1;112(5):704-15.
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New England Journal of Medicine. 2006 Jul 6;355(1):11-20.
Tsimberidou AM, Hong DS, Wheler JJ, Falchook GS, Janku F, Naing A, Fu S, Piha-Paul S, Cartwright C, Broaddus RR, Nogueras Gonzalez GM. Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine. Journal of Hematology & oncology. 2019 Dec;12:1-2.
Farinha P, Gascoyne RD. Helicobacter pylori and MALT lymphoma. Gastroenterology. 2005 May 1;128(6):1579-605.
Marshall BJ, Windsor HM. The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention. Medical Clinics. 2005 Mar 1;89(2):313-44.
Matysiak-Budnik T, Mégraud F. Helicobacter pylori infection and gastric cancer. European journal of cancer. 2006 Apr 1;42(6):708-16.
Yang H, Wei B, Hu B. Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer. Inflammation Research. 2021 Dec 1:1-2.
Zhou J, Shrestha P, Qiu Z, Harman DG, Teoh WC, Al-Sohaily S, Liem H, Turner I, Ho V. Distinct microbiota dysbiosis in patients with non-erosive reflux disease and esophageal adenocarcinoma. Journal of Clinical Medicine. 2020 Jul 8;9(7):2162.
Reddy KM, Chang JI, Shi JM, Wu BU. Risk of gastric cancer among patients with intestinal metaplasia of the stomach in a US integrated health care system. Clinical Gastroenterology and Hepatology. 2016 Oct 1;14(10):1420-5.
Sharma P, Arora A. Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis. Translational gastroenterology and hepatology. 2020;5.
Tramacere I, Negri E, Pelucchi C, Bagnardi V, Rota M, Scotti L, Islami F, Corrao G, La Vecchia C, Boffetta P. A meta-analysis on alcohol drinking and gastric cancer risk. Annals of oncology. 2012 Jan 1;23(1):28-36.
Bahadoran Z, Mirmiran P, Zarif-Yeaganeh M, Zojaji H, Azizi F. Helicobacter pylori stool antigen levels and serological biomarkers of gastric inflammation are associated with cardio-metabolic risk factors in type 2 diabetic patients. Endocrinology and Metabolism. 2015 Sep 1;30(3):280-7.
Syrjänen K. Serum biomarker panel (GastroPanel®) and slow-release L-cysteine (Acetium® Capsule): Rationale for the primary prevention of gastric cancer. EC Gastroenterology and Digestive System. 2017;3(6):172-92.
Li P, He C, Sun L, Dong N, Yuan Y. Pepsinogen I and II expressions in situ and their correlations with serum pesignogen levels in gastric cancer and its precancerous disease. BMC Clinical Pathology. 2013 Dec;13:1-0.
Cheng HC, Tsai YC, Yang HB, et al. The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of Helicobacter pylori-infected nonulcer dyspepsia. Helicobacter. 2017;22: 2017 Mar 22. [Epub ahead of print]
Wang X, Lu B, Meng L, Fan Y, Zhang S, Li M. The correlation between histological gastritis staging-‘OLGA/OLGIM’and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China. Scandinavian journal of gastroenterology. 2017 Aug 3;52(8):822-7.
Keay L, Moser PW, Wildi BS. Proteases of the genus Bacillus. II. Alkaline proteases. Biotechnology and Bioengineering. 1970 Mar;12(2):213-49.
Cheng HC, Yang YJ, Yang HB, Tsai YC, Chang WL, Wu CT, Kuo HY, Yu YT, Yang EH, Cheng WC, Chen WY. Evolution of the Correa's cascade steps: A long-term endoscopic surveillance among non-ulcer dyspepsia and gastric ulcer after H. pylori eradication. Journal of the Formosan Medical Association. 2023 May 1;122(5):400-10.
Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM. The effect of fecal occult-blood screening on the incidence of colorectal cancer. New England Journal of Medicine. 2000 Nov 30;343(22):1603-7.
Rogers CJ, Colbert LH, Greiner JW, Perkins SN, Hursting SD. Physical activity and cancer prevention: pathways and targets for intervention. Sports Medicine. 2008 Apr;38:271-96.
Garcia-Albeniz X, Chan AT. Aspirin for the prevention of colorectal cancer. Best practice & research Clinical gastroenterology. 2011 Aug 1;25(4-5):461-72.
Lin J, Manson JE, Lee IM, Cook NR, Buring JE, Zhang SM. Intakes of calcium and vitamin D and breast cancer risk in women. Archives of Internal Medicine. 2007 May 28;167(10):1050-9.
Zhan T, Yi C, Lang Y. Predicting efficacy of neoadjuvant chemotherapy in breast cancer patients with synthetic magnetic resonance imaging method MAGiC: An observational cohort study. European Journal of Radiology. 2024 Oct 1;179:111666.
Scaglione G, Arciuolo D, Travaglino A, Santoro A, Angelico G, Spadola S, Inzani F, D’Alessandris N, Raffone A, Fulgione C, Padial Urtueta B. Prognostic Value of Mandard’s Tumor Regression Grade (TRG) in Post Chemo-Radiotherapy Cervical Cancer. Diagnostics. 2023 Oct 17;13(20):3228.
Jary M, Ghiringhelli F, Jacquin M, Fein F, Nguyen T, Cleau D, Nerich V, El Gani M, Mathieu P, Valmary-Degano S, Arnould L. Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer. Cancer chemotherapy and pharmacology. 2014 Jul;74:141-50.
Wündisch T, Thiede C, Morgner A, Dempfle A, Günther A, Liu H, Ye H, Du MQ, Kim TD, Bayerdörffer E, Stolte M. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. Journal of clinical Oncology. 2005 Nov 1;23(31):8018-24.
Gong EJ, Ahn JY, Jung HY, et al. Helicobacter pylori eradication therapy is effective as the initial treatment for patients with H. pylori-negative and disseminated gastric mucosa-associated lymphoid tissue lymphoma. Gut Liv. 2016;10:706-713
Shinohara T, Maeda Y, Hamada T, Futakawa N. Survival benefit of surgical treatment for liver metastases from gastric cancer. Journal of Gastrointestinal Surgery. 2015 Jun 1;19(6):1043-51.
Venerito M, Vasapolli R, Rokkas T, Delchier JC, Malfertheiner P. Helicobacter pylori, gastric cancer and other gastrointestinal malignancies. Helicobacter. 2017 Sep;22:e12413.
Maeshima AM, Taniguchi H, Toyoda K, Yamauchi N, Makita S, Fukuhara S, Munakata W, Maruyama D, Kobayashi Y, Tobinai K. Clinicopathological features of histological transformation from extranodal marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue to diffuse large B‐cell lymphoma: an analysis of 467 patients. British journal of haematology. 2016 Sep;174(6):923-31.
Kuo SH, Chen LT, Lin CW, Yeh KH, Shun CT, Tzeng YS, Liou JM, Wu MS, Hsu PN, Cheng AL. Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL. Blood, The Journal of the American Society of Hematology. 2017 Jan 12;129(2):188-98.
Raderer M, Isaacson PG. Extranodal lymphoma of MALT-type: perspective at the beginning of the 21st century. Expert Review of Anticancer Therapy. 2001 Jun 1;1(1):53-64.
Fernandez C, Bellosillo B, Ferraro M, Seoane A, Sanchez-Gonzalez B, Pairet S, Pons A, Barranco L, Vela MC, Gimeno E, Colomo L. MicroRNAs 142-3p, miR-155 and miR-203 are deregulated in gastric MALT lymphomas compared to chronic gastritis. Cancer Genomics & Proteomics. 2017 Jan 1;14(1):75-82.
Blosse A, Levy M, Robe C, Staedel C, Copie-Bergman C, Lehours P. Deregulation of miRNA in Helicobacter pylori-induced gastric MALT lymphoma: from mice to human. Journal of clinical medicine. 2019 Jun 13;8(6):845.
Floch P, Capdevielle C, Staedel C, Izotte J, Sifré E, Laur AM, Giese A, Korolik V, Dubus P, Mégraud F, Lehours P. Deregulation of microRNAs in gastric lymphomagenesis induced in the d3Tx mouse model of Helicobacter pylori infection. Frontiers in Cellular and Infection Microbiology. 2017 May 16;7:185.
Herrera-Goepfert R, Onate-Ocana LF, Mosqueda-Vargas JL, et al. Methylation of DAPK and THBS1 genes in esophageal gastric-type columnar metaplasia. World J Gastroenterol. 2016;22:4567-4575.
Segal I, Ally R, Mitchell H. Helicobacter pylori—an African perspective. Qjm. 2001 Oct 1;94(10):561-5.
Lee JY, Park HW, Choi JY, et al. Helicobacter pylori Infection with atrophic gastritis is an independent risk factor for advanced colonic neoplasm. Gut Liv. 2016;10:902-909
Futagami S, Hiratsuka T, Shindo T, Horie A, Hamamoto T, Suzuki K, Kusunoki M, Miyake K, Gudis K, Crowe SE, Tsukui T. Expression of apurinic/apyrimidinic endonuclease‐1 (APE‐1) in H. pylori‐associated gastritis, gastric adenoma, and gastric cancer. Helicobacter. 2008 Jun;13(3):209-18.
Chung HW, Kim JW, Lee JH, Song SY, Chung JB, Kwon OH, Lim JB. Comparison of the validity of three biomarkers for gastric cancer screening: carcinoembryonic antigen, pepsinogens, and high sensitive C-reactive protein. Journal of clinical gastroenterology. 2009 Jan 1;43(1):19-26.
Beydoun MA, Beydoun HA, Shroff MR, Kitner-Triolo MH, Zonderman AB. Helicobacter pylori seropositivity and cognitive performance among US adults: evidence from a large national survey. Psychosomatic medicine. 2013 Jun 1;75(5):486-96.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Dr Arjun Aravindh, Dr Debananda Sahoo, Sarika Baburajan Pillai, Dr. John Abraham, Dr. V. Bharathi, Dr. T.S Durga Prasad, Dr. Veena Maheshwari
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
